Author: Customer Service

MOCKSVILLE, N.C., Sept. 05, 2025 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced that Larry Firestone, Chief Executive Officer, and Dan Otto, Chief Financial Officer, will host investor meetings on Tuesday, September 9, 2025 as part of the HC Wainwright Conference taking place at the Lotte New York Palace Hotel. Investors can register and request meetings via their HC Wainwright representative or 22nd Century Investor Relations at mkreps@xxiicentury.com. About 22nd Century Group, Inc. 22nd Century Group is pioneering the nicotine harm reduction movement in the tobacco industry enabling smokers to take control of their nicotine consumption. We created our...

HOUSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today that Sunit Patel, Crown Castle’s Executive Vice President and Chief Financial Officer is scheduled to present on Wednesday, September 17, 2025 at 9:30 a.m. Eastern Time at the 2025 RBC Capital Markets Global Communications Infrastructure Conference. The presentation will be broadcast live over the Internet and is expected to last approximately 20 minutes. The live audio webcast link and presentation for the conference will be available on Crown Castle’s website at www.crowncastle.com, where it will also be archived for replay. ABOUT CROWN CASTLE Crown Castle owns, operates and leases approximately 40,000 cell towers and approximately 90,000 route miles of fiber supporting small cells and fiber solutions across every...

EVANSVILLE, Ind., Sept. 05, 2025 (GLOBE NEWSWIRE) — Old National Bancorp (NASDAQ: ONB) announced today that its Chairman and Chief Executive Officer Jim Ryan will present at the 2025 Barclays Global Financial Services Conference in New York, NY at 2:45 p.m. ET on Monday, September 8, 2025. Interested parties can access the live webcast of the presentation through the Investor Relations section of the Company’s website at https:/ir.oldnational.com. For those unable to attend the live broadcast, a replay of the presentation will be accessible for 180 days after the presentation date. ABOUT OLD NATIONAL Old National Bancorp is the holding company of Old National Bank. As the sixth largest commercial bank headquartered in the Midwest, Old National proudly serves clients primarily in the Midwest and Southeast. With approximately $71...

ROCHESTER, NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) — Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a leading provider of technology products to defense, biomedical, communications, and consumer industry leaders, today announced the launch of an apprenticeship program created to be New York State certified and funded. The program is intended to cultivate the next generation of highly skilled manufacturing technicians and is the first of its kind in the United States. Developed in partnership with the Rochester Technology and Manufacturing Association (RTMA) and Monroe Community College (MCC), the program addresses the critical need for specialized talent in the optics and photonics manufacturing sector. The curriculum was developed by Chief Engineer Ryan Kromm and former Senior Technician Mark...

MONTEVIDEO, Uruguay, Sept. 05, 2025 (GLOBE NEWSWIRE) — DLocal Limited (“dLocal”), (NASDAQ:DLO) a technology-first payments platform, today announced the closing of a previously announced secondary offering of 17,250,000 Class A common shares (including 2,250,000 Class A common shares pursuant to the full exercise of the underwriters’ option) by an entity associated with General Atlantic at a price to the public of $12.75 per share. The Company is not selling any Class A common shares in the offering and will not receive any proceeds from the offering. The offering was made through an underwriting group led by J.P. Morgan, Goldman Sachs & Co. LLC and Morgan Stanley, who are acting as global coordinators and joint bookrunners and BTG Pactual and Citigroup who are acting as joint bookrunners. The Company has filed an automatically...

Lawrence Livermore National Laboratory(LLNL) STARFIRE DIODE TECHNOLOGY WORKING GROUPCOHERENT JOINS LLNL’S STARFIRE DIODE TECHNOLOGY WORKING GROUP TO ADVANCE INERTIAL FUSION ENERGYSAXONBURG, Pa., Sept. 05, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in photonics, announced today its membership in the Diode Technology Working Group within the STARFIRE Hub, a collaborative initiative led by Lawrence Livermore National Laboratory (LLNL) to accelerate the development of inertial fusion energy (IFE). This collaboration reflects Coherent’s commitment to pushing the boundaries of photonics to address the world’s most complex energy challenges. By working alongside other leading institutions and industry partners, we look forward to shaping the future of high-power diode technology and supporting the development...

BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on September 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 85,000 shares of Class A common stock and restricted stock units (RSUs) underlying 45,250 shares of Class A common stock to eight (8) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4). Each stock option granted on September 4, 2025 has an exercise price per share equal to $21.90, Vera’s closing trading price on September 4, 2025. Each stock option will vest over four years,...

SOLANA BEACH, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced the closing of its previously announced underwritten public offering of 640,924 shares of its common stock at a price to the public of $4.40 per share and pre-funded warrants to purchase up to 40,894 shares of Artelo’s common stock at a price to the public of $4.399 per pre-funded warrant, which represents the per share public offering price of each share of Artelo’s common stock less the $0.001 per share exercise price for each pre-funded warrant. The aggregate gross proceeds from the offering were approximately $3.0 million, prior...